| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
37,951,000 |
| Market
Cap: |
440.23(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.03 - $13.46 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.1 |
| Insider 6 Months : 11.1 |
| Insider 3/6 Months : 22.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile AgeX Therapeutics is a biotechnology company focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows it to utilize telomerase-expressing regenerative pluripotent stem cell (PSC) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s product candidates in the discovery stage include two cell-based therapies derived from telomerase-positive PSCs and two product candidates derived from its proprietary induced Tissue Regeneration technology.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
32,586 |
32,586 |
32,586 |
32,586 |
| Total Buy Value |
$312,736 |
$312,736 |
$312,736 |
$312,736 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
10 |
10 |
10 |
10 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  West Michael D |
Chief Executive Officer |
• • – |
2021-09-11 |
4 |
D |
$1.00 |
$1,078 |
D/D |
(1,081) |
36,527 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2021-09-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
37,608 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2021-06-11 |
4 |
D |
$1.53 |
$1,654 |
D/D |
(1,081) |
34,483 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2021-06-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
35,564 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2021-03-11 |
4 |
D |
$2.03 |
$2,607 |
D/D |
(1,284) |
32,439 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2021-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
33,723 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2020-12-11 |
4 |
D |
$1.69 |
$1,827 |
D/D |
(1,081) |
30,598 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2020-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
31,679 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2020-09-11 |
4 |
D |
$0.81 |
$875 |
D/D |
(1,081) |
28,554 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2020-09-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
29,635 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2020-06-11 |
4 |
D |
$0.80 |
$865 |
D/D |
(1,081) |
26,510 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2020-06-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
27,591 |
|
- |
|
| Park Andrea Eun Jae |
Chief Financial OfficerOfficer |
• – – |
2020-05-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
351 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2020-03-11 |
4 |
D |
$0.88 |
$4,463 |
D/D |
(5,085) |
24,446 |
|
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2020-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
29,551 |
|
- |
|
| Juvenescence Ltd |
10% Owner |
– – • |
2019-08-13 |
4 |
B |
$0.00 |
$0 |
D/D |
19,000 |
16,419,000 |
2.37 |
- |
|
| West Michael D |
Chief Executive Officer |
• • – |
2018-12-10 |
4 |
B |
$3.86 |
$15,443 |
D/D |
4,000 |
15,460 |
2.81 |
- |
|
| Mauldin John F |
Director |
– • – |
2018-11-27 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
125,000 |
|
- |
|
43 Records found
|
|
Page 2 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
1.20 (9.38%) 
